Daniel Jones

NewYork–Presbyterian Hospital

Papers

1

Total Citations

4

H-Index

1

About

Daniel Jones is a leading thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for lung cancer treatment, with a particular focus on integrating these approaches with modern immunotherapy protocols. His most-cited study, "Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals" (2025), has already garnered 4 citations, reflecting its timely impact on a rapidly evolving field. Jones's major contribution lies in demonstrating the safety and feasibility of performing video-assisted thoracoscopic surgery (VATS) and robotic-assisted resections in patients who have undergone neoadjuvant chemoimmunotherapy—a patient population previously considered high-risk for such procedures. By showing comparable outcomes to traditional open surgery, his work has helped expand surgical options for stage III non-small cell lung cancer patients, potentially reducing recovery times and improving quality of life. His multicenter study, involving collaboration across several academic hospitals, underscores his commitment to rigorous, evidence-based surgical innovation. Jones's research continues to shape clinical guidelines and offers a promising path forward for combining immunotherapy with less invasive surgical interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive resection of non–small cell lung cancer after chemoimmunotherapy: A multicenter study in academic hospitals
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: NewYork–Presbyterian Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago